Hero image

About our company

We invent for a more hopeful future.

We aspire to be the premier research-intensive biopharmaceutical company in the world

For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.

We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.

Watch highlights of our discoveries and commitments from the start of our company to today.

MSD about us video
women harvesting tea leaves with basket
Responsibility

The heart of our mission

We believe corporate responsibility is about our health, social, environmental and economic impact on people and communities around the world.

Illustration of leaders speaking on stage
Leadership

The team that guides our work

Our leaders focus on our mission to save and improve lives around the world. This is the foundation of everything we do.

Our company by the numbers

74K

employees

Our culture
$13.6B

research and development investment in 2020

Our research
$3.1B

total philanthropy in 2019

Our giving
group of scientists working together in lab
Culture & values

Our values are driven by a desire to improve life

We’ve built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration.

Get to know us through our stories

Learn about the heartbeat of our company.

View our stories

Podcast: What’s the next frontier in the fight against cancer?

Listen in as leaders from our research and oncology divisions discuss the potential of antibody drug conjugates

Read more

Next: Podcast: What’s the next frontier in the fight against cancer?

Taking the fight against COVID-19 on the road

How a 39-foot Winnebago is helping to raise awareness about clinical trials

Read more

Next: Taking the fight against COVID-19 on the road

MSD publishes 2020/2021 Environmental, Social and Governance (ESG) Progress Report

Letter from our chief executive officer and president, Robert M. Davis

Read Rob's letter

Next: MSD publishes 2020/2021 Environmental, Social and Governance (ESG) Progress Report

Supporting Australian patient communities through COVID-19

Three local health consumer organizations have received COVID-19 Regional Grants from MSD to support their pandemic response efforts for cancer patients and their families

Read more

Next: Supporting Australian patient communities through COVID-19

How one senior manages type 2 diabetes

Texan Jerry Kreiner shares how taking his type 2 diabetes diagnosis seriously helped him to still be able to do the things he loves today

Read more

Next: How one senior manages type 2 diabetes

Podcast: What’s the next frontier in the fight against cancer?

Listen in as leaders from our research and oncology divisions discuss the potential of antibody drug conjugates

Read more

Next: Podcast: What’s the next frontier in the fight against cancer?

Taking the fight against COVID-19 on the road

How a 39-foot Winnebago is helping to raise awareness about clinical trials

Read more

Next: Taking the fight against COVID-19 on the road

MSD publishes 2020/2021 Environmental, Social and Governance (ESG) Progress Report

Letter from our chief executive officer and president, Robert M. Davis

Read Rob's letter

Next: MSD publishes 2020/2021 Environmental, Social and Governance (ESG) Progress Report

Supporting Australian patient communities through COVID-19

Three local health consumer organizations have received COVID-19 Regional Grants from MSD to support their pandemic response efforts for cancer patients and their families

Read more

Next: Supporting Australian patient communities through COVID-19

How one senior manages type 2 diabetes

Texan Jerry Kreiner shares how taking his type 2 diabetes diagnosis seriously helped him to still be able to do the things he loves today

Read more

Next: How one senior manages type 2 diabetes

Previous
Next

Our areas of focus

We focus on scientific innovation to deliver medicines and vaccines that may help millions of people around the world.

Oncology

Our mission is to deliver innovations that extend and improve the lives of people with cancer.

Learn about oncology

Vaccines

Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.

Learn about vaccines

Infectious diseases

We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.

Learn about infectious diseases

COVID-19

As a company dedicated to saving and improving lives, we have a special responsibility to help in the fight against COVID-19. We’ve been fully committed to developing an effective response to the COVID-19 pandemic since it was first recognized.

Learn more about our response to COVID-19

Cardio-metabolic disorders

We are determined to find solutions for the most serious chronic health challenges, such as cardiovascular disease and diabetes.

Learn about cardio-metabolic disorders

Discovery & development

We are pushing the boundaries in research where we can make the greatest difference, now and in the future.

Learn about our work

Dog owner holding out a ball for an attentive Labrador

MSD Animal Health

MSD Animal Health is a research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services.

We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.

Business partnerships and public policies keep our patients in focus

Column one image

Business development & licensing

We work with partners, from early-stage science to clinical-stage programs, to deliver new therapies to patients.

Column one image

Policies & positions

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.